A progressive extrapyramidal syndrome and dementia occurred in three members of one family. The age of onset was in the seventh decade and the affected individuals showed many of the clinical features of progressive supranuclear palsy (PSP). Necropsy of one individual revealed the neuropathological features of PSP. We propose that this family has a familial form of PSP and review the evidence in the literature that a familial form exists. (7 Neurol Neurosurg Psychiatry 1993;56:473-476) 
Progressive supranuclear palsy (PSP) was first defined as a clinical and pathological syndrome by Steele et al in 1964.1 They described a series of nine patients with a combination of a supranuclear gaze palsy, dementia, axial and limb rigidity, and pseudobulbar palsy. Seven of the nine were studied pathologically and showed neuronal loss, granulovacuolar degeneration, gliosis, and neurofibrillary tangles affecting mainly subcortical structures. They recognised some variation in the clinical presentation of their patients. In the majority the dementia was mild, but three patients with a more severe dementia were included in the series because they had oculomotor and neuropathological abnormalities similar to the other cases. Psychometric studies in PSP reveal a subcortical dementia2 with evidence of frontal lobe dysfunction.' Positron emission tomography shows a frontal deficit in both cerebral blood flow and glucose utilisation studies. 45 We describe the clinical features of three members of one family who developed dementia with extrapyramidal features in their sixties. One individual had a post mortem examination which showed the pathological appearances of progressive supranuclear palsy. We discuss the diagnosis in this family and review other cases of possible familial PSP.
Methods
This family contacted us as a result of our studies into familial Alzheimer's disease. Two members of the family, the proband (3 5) and her cousin (3-1), were seen by us. The proband had a post mortem examination. The pedigree is shown in fig 1. INDIVIDUAL 3 5 The proband presented with a depressive illness at age 62 years. She was started on lofepramine 70 mg per day. Two years later she developed an unsteady gait, tended to veer to the left, and had several falls. Her memory began to deteriorate and she complained of episodes of transient difficulty in speaking. On examination the only abnormalities found were poor coordination of the left hand and absent ankle jerks. Neuropsychological testing showed a verbal IQ of 91 and performance of 86 (WAIS-R); her estimated premorbid IQ was 112 (Schonell graded word test) and she had difficulties with visuospatial tasks. Specific tests of frontal lobe function were not done. A brain CT scan showed moderate enlargement of the ventricles with generalised atrophy with slight speckled calcification in both corpora striata. She was started on aspirin.
Over the next six months she complained of intermittent double vision, pressure behind her eyes, insomnia, and dysphagia particularly for solids. She retained some insight into her illness. When seen by one of us (PR) one year later she walked with a Zimmer frame and needed help with all activities of daily living. She had a tremor of the left hand and increased tone in all limbs. She spoke extremely slowly. Her Mini-Mental test6 score was 23. Her disabilities fluctuated. Over the next year she deteriorated until she died aged 71. Necropsy was performed and neuropathological findings are described below.
INDIVIDUAL [2] [3] [4] The mother of the proband presented with depression and personality change aged 69 years. She became unsure of her balance and worried that young children might knock her over. Her hands became clumsy and painful. A diagnosis of Parkinson's disease was suggested but she had no treatment. She became aggressive and cruel in her conversation. Over the next two years she developed severe dysarthria, became wheelchair bound, and, at the age of 72 the avidin biotin complex (Amersham, UK) with the following antibodies: BF10 (a monoclonal antibody to the phosphorylated medium weight polypeptide of neurofilaments), RT-97 and 147, (both monoclonal antibodies to the phosphorylated heavy weight neurofilament polypeptide), tau and BA4 (12-28) (all kindly provided by Professor BH Anderton, Institute of Psychiatry, London), ubiquitin and GFAP (both Dako, UK).
On histology, the major finding was of neurofibrillary tangles, some flame shaped, some globose, in the locus coeruleus, pontine nuclei, substantia nigra, inferior olivary nuclei, dentate nucleus, arcuate nucleus, raphe nuclei, globus pallidus, and nucleus basalis of Meynert. There were only very few tangles in the amygdala, hippocampus and parahippocampal gyri, or in the neocortical areas. Quantitative assessment was not carried out, but in the locus coeruleus, which was symmetrically affected, about 50% of the neurons contained tangles. A few plaques were seen only in subpial zone of the amygdala and the BA4 deposits were few and small. Granulovacuoles were seen in the substantia nigra and pontine nuclei, but not in the cortical areas. Silver impregnation according to Gallyas revealed many neuropil threads in the cortex. Very few cells remained in the dentate nucleus and the superior cerebellar peduncle was pale. Grumose change was seen around many dead or dying dentate nerve cells. The olivary nuclei were not, however, enlarged, nor was there evidence of extensive arborisation of dendrites or nerve cell hypertrophy. There was extraneuronal pigment in the substantia nigra and locus coeruleus. The hippocampus showed a tiny old infarct.
The neurofibrillary tangles gave a strongly positive reaction with antibodies to tau protein (fig 2) , but were negative or weakly positive with ubiquitin, and were entirely negative with antibodies BF10, RT97, and 147. There was patchy, moderate astrocytosis, demonstrated by GFAP, in many areas of the deep grey matter. absence of plaques is most consistent with progressive supranuclear palsy. The striking paucity of tangles and plaques in the hippocampus is against the diagnosis of Alzheimer's disease.
Discussion
Three members of this family developed a dementia, extrapyramidal syndrome, gait disturbance, and dysarthria in their sixties. This combination of symptoms and signs is very unusual and is unlikely to have occurred by chance; they are the commonest presenting features in PSP. 7 The patient examined by a neurologist would fulfil clinical criteria for the diagnosis of PSP8 were it not for her positive family history. One individual had a neuropathological examination which showed the changes of PSP. The involvement of two generations and a cousin makes a common environmental factor unlikely and suggests this disease is a genetic one; the mode of inheritance is compatible with an autosomal dominant gene. Therefore we suggest that these individuals have a familial form of PSP.
There is some variation in the features between the family members but this is well within the spectrum reported in other autosomal dominant dementias such as familial prion disease. 18 Our findings have two important implica-tions. Firstly, they show that PSP may affect the brain more extensively and more profoundly than previously envisaged: the pathological process may disrupt the neuronal cytoskeletal system more severely, resulting not only in tangles, but also in neuropil threads affecting both the subcortical grey matter and neocortex. Secondly, this hitherto unrecognised involvement of the neocortex must be a substantial factor in bringing about dementia, explaining some of the atypical cases presenting with late onset dementia, but without characteristic Alzheimer's disease pathology. From this it follows that the concept of PSP as a pure subcortical dementia should be reassessed.
There is some evidence in the literature for a familial form of PSP. Mata and colleagues'9 reported a family of three siblings who developed a disease with dementia, kyphoscoliosis, pes cavus, rigidity, and pyramidal signs in their twenties. One member of this pedigree had a postmortem examination which showed many of the features of PSP (although the filaments were not examined ultrastructurally20). However many of the clinical manifestations in this family are not features of sporadic PSP. Ohara et al 21 reported two siblings of a consanguineous marriage who developed a clinical syndrome similar to PSP. Necropsy in one patient revealed extensive neurofibrillary degeneration with prominent involvement of the limbic system. The neuropathological changes were atypical and the authors were unsure how to classify their disease. In addition to these two families one of the early series of PSP patients included a patient whose mother suffered from a similar illness.22 In many of the reports of sporadic PSP it is unclear how carefully the family history was assessed.
There has been one case control study of PSP which examined the personal histories of 50 cases of PSP and 100 age and sex matched controls.2' No definite familial cases were found but a family history of Parkinson's disease was 5-0-6-0 times commoner in affected patients than controls and a family history of Alzheimer's disease was 1 3-3-6 times commoner. These figures were not statistically significant and the authors explained the increase with higher awareness of these diseases in the families of patients with PSP. An alternative explanation is that these relatives had PSP, perhaps in atypical form, but received the diagnosis of Parkinson's disease or Alzheimer's disease. This occurred in our family. The late onset of symptoms may conceal the familial nature in some pedigrees due to unrelated morbidity and mortality before the age of onset. If the disease gene has low penetrance then a significant proportion of cases could be genetic.
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